Adherence to ustekinumab in psoriasis patients

Journal of Drugs in Dermatology

Volumn 12, Issue 10, 2013, Pages 1090-1092

  Sandoval, Laura F ^a   Huang, Karen E ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

USTEKINUMAB;

ADULT; CLINICAL ARTICLE; DRUG COST; FEMALE; HEALTH INSURANCE; HUMAN; MALE; PATIENT COMPLIANCE; PSORIASIS; REVIEW;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ETHNIC GROUPS; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSORIASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84885453730     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Thorneloe RJ, Bundy C, Griffiths CE et al. Adherence to medication in patients with psoriasis: a systematic literature review. Br J Dermatol 2013;168:20-31.
2. Chan SA, Hussain F, Lawson LG et al. Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities. J Dermatolog Treat 2013;24:64-69.
3. Bewley A, Burrage DM, Ersser SJ et al. Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational twostage qualitative and quantitative study. J Eur Acad Dermatol Venereol 2013.
4. Bhosle MJ, Feldman SR, Camacho FT et al. Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J Dermatolog Treat 2006;17:294-301.
5. Blum MA, Koo D, Doshi JA. Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review. Clin Ther 2011;33:901-913.
6. Balkrishnan R, Carroll CL, Camacho FT et al. Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003;49:651-654.
7. Carroll CL, Feldman SR, Camacho FT et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004;51:212-216.
8. West C, Narahari S, O'Neill J et al. Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J. In press.
9. Stelara Prescribing Information. Available at http://www.stelarainfo.com/ pdf/ PrescribingInformation.pdf. Accessed June 1, 2013.
10. Fenerty SD, West C, Davis SA et al. The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence 2012;6:127-135.
11. Shi L, Hodges M, Yurgin N et al. Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006). Expert Rev Pharmacoecon Outcomes Res 2007;7:187-202.
12. Schaarschmidt ML, Umar N, Schmieder A et al. Patient preferences for psoriasis treatments: impact of treatment experience. J Eur Acad Dermatol Venereol 2013;27:187-198.